# A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

> **NCT03695835** · — · COMPLETED · sponsor: **Gary Onik MD** · enrollment: 27 (actual)

## Conditions studied

- Adenocarcinoma

## Interventions

- **DRUG:** Immunotherapeutic Agents
- **DEVICE:** Ablation

## Key facts

- **NCT ID:** NCT03695835
- **Lead sponsor:** Gary Onik MD
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-11
- **Primary completion:** 2019-07-08
- **Final completion:** 2020-06-17
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03695835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03695835, "A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03695835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*